Pharmaceuticals - Indian - Bulk Drugs & Formln M/S
Particulars (in ₹ Cr.) | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
---|---|---|---|---|---|
Total Revenue | 507.99 | 544.01 | - | - | - |
Total Expenses | 318.03 | 349.88 | - | - | - |
Profit Before Tax | 184.66 | 194.13 | - | - | - |
Profit After Tax | 135.79 | 144.96 | - | - | - |
Operating Profit after Depreciation | 195.27 | 201.50 | - | - | - |
Particulars (in ₹ Cr.) | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
---|---|---|---|---|---|
Fixed Assets | 138.92 | 107.16 | - | - | - |
Total Non Current Assets | 146.24 | 126.59 | - | - | - |
Total Current Assets | 390.03 | 248.80 | - | - | - |
TOTAL ASSETS | 536.27 | 375.39 | - | - | - |
Total Shareholder's Fund | 339.82 | 201.42 | - | - | - |
Particulars (in ₹ Cr.) | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 129.28 | 122.73 | - | - | - |
Net Cash used in Investing Activities | -50.73 | -45.24 | - | - | - |
Net Cash used in Financing Activities | -27.50 | -72.50 | - | - | - |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 740.46 | 744.94 | 702.88 | 507.71 | 543.91 |
Total Expenses | 510.62 | 528.33 | 459.65 | 317.23 | 350.03 |
Profit Before Tax | 220.09 | 216.61 | 243.23 | 190.49 | 193.88 |
Profit After Tax | 163.75 | 160.03 | 181.59 | 141.62 | 144.71 |
Operating Profit after Depreciation | 230 | 217.97 | 246.53 | 195.79 | 201.25 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 171.94 | 151.04 | 156.48 | 138.92 | 107.16 |
Total Non Current Assets | 353.21 | 197.02 | 165.03 | 144.44 | 116.39 |
Total Current Assets | 705.64 | 665.05 | 548.35 | 389.12 | 247.84 |
TOTAL ASSETS | 1,058.85 | 862.07 | 713.38 | 533.56 | 364.23 |
Total Shareholder's Fund | 845.22 | 681.49 | 521.54 | 339.82 | 198.21 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 241.26 | 141.56 | 146.42 | 136.78 | 122.40 |
Net Cash used in Investing Activities | -263.76 | -147.25 | -76.03 | -60.98 | -45.24 |
Net Cash used in Financing Activities | -1.99 | -4.24 | -56.15 | -20.55 | -72.50 |
No data available
Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
---|---|---|---|---|---|
Total Revenue | 208.26 | 162.90 | 183.95 | 166.76 | 181.35 |
Total Expenses | 138.77 | 118.64 | 130.88 | 112.17 | 118.73 |
Profit Before Tax | 76.92 | 49.47 | 54.15 | 43.70 | 64.32 |
Profit After Tax | 58.35 | 37.78 | 39.65 | 32.11 | 47.87 |
Operating Profit after Depreciation | 81.56 | 52.98 | 61.90 | 61.34 | 70.83 |
₹1/Share
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Blue Jet Healthcare Ltd | ₹581 | ₹10,078.34 |
Sun Pharmaceuticals Industries Ltd | ₹1,761.80 | ₹4,22,714.84 |
Divis Laboratories Ltd | ₹5,818.40 | ₹1,54,460.24 |
Cipla Ltd | ₹1,427.30 | ₹1,15,270.75 |
Dr Reddys Laboratories Ltd | ₹1,288.45 | ₹1,07,511.36 |
Torrent Pharmaceuticals Ltd | ₹3,157.60 | ₹1,06,862.73 |
23 Oct 2024, 04:17 pm
12 Aug 2024, 03:31 pm
02 Aug 2024, 11:04 am
27 May 2024, 10:47 am
18 May 2024, 03:37 pm